Immatics N.V. (IMTX)

NASDAQ

$6.75

$-0.19

(-2.71%)

Pre-Market

Immatics N.V. (IMTX) Live Price Chart

Last updated: ⁦2026-10-15 08:59:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Immatics N.V. (IMTX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $6.75, with a market capitalization of $1.04B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.73 to $12.41. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.04B
Open	$6.94
Day's High	$18.42
Day's Low	$3.30
Previous Close	$7.00
Volume	1.01K
Average Volume	659.96K
P/E Ratio	--
52-Week High	$12.41
52-Week Low	$6.73
Dividend Yield	--
Earnings Date	--

Immatics N.V. (IMTX) Pre-Market Stock Price

Immatics N.V. (IMTX) is trading at $6.75 in pre-market trading as of 2026-10-15 08:56:00, down 3.56% ($0.25) from the previous close of $7.00

Pre-market trading shows how investors are pricing IMTX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Immatics N.V. (IMTX) 7-Day Stock Price Change

Over the past seven days, Immatics N.V. (IMTX) moved from $7.50 to $6.75, representing a decline of 9.99% ($0.75).

The stock traded between $6.73 and $7.81 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.02 million shares, up versus the previous seven-day period, indicating higher trading activity.

IMTX 52-Week Price Position

Position in Range: 0.4%

52W Low$6.73

52W High$12.41

IMTX is currently trading at $6.75, placing it 0.4% of the way from its 52-week low of $6.73 to its 52-week high of $12.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Immatics N.V. (IMTX)?

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Immatics N.V. Information

Employees	407
Exchange	NASDAQ
Company Website	https://www.immatics.com

How to Buy Immatics N.V. (IMTX) Stock on MEXC

Eligible investors can buy real shares of Immatics N.V. (IMTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IMTX and Place Your Order

Open the RealStocks trading page and search for IMTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Immatics N.V. (IMTX) stock price today?

Immatics N.V. (IMTX) is currently trading at $ 6.75, down 3.56% ($0.25) from the previous close of $ 7.00. Intraday prices update in real time during regular trading hours.

2.Is IMTX stock going up or down today?

As of 2026-10-15 08:56:00, IMTX is trading at $ 6.75, down 3.56% ($0.25) from its previous close of $ 7.00. The stock has traded between $ 3.30 and $ 18.42 during today’s regular session. Past price movements do not guarantee future results.

3.What is IMTX pre-market price?

As of 2026-10-15 08:56:00, IMTX is trading at $ 6.75 in pre-market trading, down 3.56% ($0.25) from the previous close of $ 7.00. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IMTX after-hours price?

As of 2026-10-15 08:56:00, IMTX is trading at $ 6.94 in after-hours trading, down 0.86% ($0.06) from the regular-session close of $ 7.00. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IMTX stock trading now?

IMTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IMTX sit relative to its 52-week high and low?

Over the past 52 weeks, IMTX has traded between a low of $ 6.73 and a high of $ 12.41. At $ 6.75, the stock is positioned 0.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Immatics N.V. in?

Immatics N.V. (IMTX) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Immatics N.V.'s market capitalization and where is it listed?

Immatics N.V. is listed on the NASDAQ exchange with a market capitalization of $ 1.04B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IMTX valued in terms of P/E ratio and EPS?

IMTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Immatics N.V. pay a dividend?

Immatics N.V. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.